A 2023 survey by the Indian Council of Medical Research (ICMR) and the Madras Diabetes Research Foundation (MDRF) found that 28.6 percent of Indians — about 25.4 crore people — are affected by ...

Wegovy’s price cut follows Mounjaro’s success in IndiaIndia key market for Novo Nordisk and Eli Lilly’s obesity drugsWegovy’s ...

The announcement comes as the Danish drugmaker struggles to grab significant market share in the Indian market before it ...

Oliver Barnes Pfizer and Novo Nordisk duked it out for who will own Metsera — a coveted biotech that’s developing ...

Novo Nordisk has reduced the prices of Wegovy by 37%. The obesity pen's lowest dose of 0.25 mg will sell at Rs 10,850 for a ...

Wegovy entered India in June and is playing catch-up to Eli Lilly's Mounjaro, whose sales have doubled within months of its ...

The company's shares (LLY) climbed 2.3% Tuesday to end at $988.62 a share, after closing at a record high of $966.64 on Monday. The rally has pushed Lilly's market capitalization up to $934.6 billion, ...

Lower prices for 15 drugs, including Ozempic and Wegovy, are expected to be announced by the end of the month. The price ...

The company's shares (LLY) climbed 2.5% in afternoon trading on Tuesday, after closing at a record high of $966.64 on Monday. That rally pushed Lilly's market capitalization up to $937 billion, ...

Novo Nordisk has cut prices of its weight-loss drug Wegovy by up to 37% in India. This move intensifies competition with Eli ...

Danish drugmaker Novo Nordisk on Tuesday cut the price of its blockbuster weight-loss drug, Wegovy, by up to 33% in India, ...

Eli Lilly and Novo Nordisk agreed to discount their GLP-1 medications from $1350 per month to around $245 to $350 per month.